Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL R *** > Treatment > Co: USA. S. BrentuxiMAb Vedotin>>

---

Co: USA. S. BrentuxiMAb Vedotin>>'s subsections
(*) USA Approval Date: 2017. 11.09
>Received Prior Systemic Therapy
>SubTypes>
Company
TradeMark

Co: USA. S. BrentuxiMAb Vedotin>>'s products
This section has no products